Interim analysis of a randomized study of 1L BMS-986012 (anti-fucosyl-GM-1) with Chemotherapy and nivolumab in ES-SCLC

Activiteit: Academic presentation › Academic

Periode6-mrt.-2025
EvenementstitelJSMO 2025: The Japanese Society of Medical Oncology Annual Meeting
EvenementstypeConference
LocatieKobe, JapanToon op kaart
Mate van erkenningInternational